{"url":"https://nivawealth.com/firms/rtw-investments-153232","iapdUrl":"https://adviserinfo.sec.gov/firm/summary/153232","regulatoryAum":14137925887,"crd":"153232","secFileNumber":"801-78183","legalName":"RTW Investments LP","displayName":"RTW Investments","website":null,"linkedinUrl":"https://www.linkedin.com/company/rtw-investments-llc/","founded":null,"organization":"Delaware limited partnership","fiscalYearEnd":"December","headquarters":{"street":"40 10th Avenue, 7th Floor","city":"New York","state":"NY","stateName":"New York","country":"United States","postalCode":"10014"},"tradeNames":[],"registration":{"secApproved":"13 June 2013","noticeFilings":null,"latestNoticeFiling":null},"staff":{"employees":70,"advisory":35,"brokerDealerReps":0,"insuranceAgents":0,"promoters":0},"aum":{"discretionary":14137925887,"discretionaryAccounts":10,"nonDiscretionary":0,"nonDiscretionaryAccounts":0,"wrapProgram":null,"nonUsClientsPct":70,"nonAumClients":0},"clientTypes":[{"label":"Pooled investment vehicles","clients":10,"regulatoryAum":14137925887}],"fees":[],"feeNotes":[],"feePrograms":[],"brochureCoverage":{"scope":"known_documents","status":"not_processed","checkedAt":null,"documents":[]},"custodians":[],"custodyNote":"RTW Investments has custody of $9.52B for 3 clients.","otherCustodians":[],"leadership":[{"name":"Peter Fong","title":"Partner, President","crd":"7522105"},{"name":"Robert Aurigema","title":"Partner, Chief Operating Officer and Chief Financial Officer","crd":"2162627"},{"name":"Darshan Patel","title":"Chief Compliance Officer, General Counsel","crd":"4477767"},{"name":"Josh Kennedy-Smith","title":"Partner, Research Analyst","crd":"8057848"},{"name":"Gotam Makker","title":"Partner, Head of Strategic Investments","crd":"4145096"},{"name":"Tony Nguyen","title":"Partner, Research Analyst","crd":"8235763"},{"name":"Christopher Seiter","title":"Chief Corporate Finance Officer","crd":"2580835"},{"name":"Stephanie Sirota","title":"Partner, Chief Business Officer","crd":"2926147"},{"name":"Roderick Wong","title":"Managing Partner, Chief Investment Officer","crd":"4718563"},{"name":"Naveen Yalamanchi","title":"Partner, Portfolio Manager","crd":"6113041"}],"ownership":[{"label":"Roderick Wong","detail":"Managing partner, chief investment officer in the 50% to 75% ownership band and a control person, since September 2009."},{"label":"Naveen Yalamanchi","detail":"Partner, portfolio manager in the 5% to 10% ownership band and a control person, since January 2016."}],"branchOffices":null,"filedOffices":{"otherThanPrincipal":0,"privateResidences":0},"listedOfficeAddresses":1,"officesByState":[{"state":"New York","offices":1,"addresses":[{"street":"40 10th Avenue, 7th Floor","city":"New York","headquarters":true}]}],"advFacts":{"source":{"file":"ia100226.zip","asOf":"2 October 2026"},"telephone":"646-597-6980","stateRegisteredReps":0,"otherAdviserReps":0,"compensation":["A percentage of assets under management","Performance-based fees"],"activities":["Portfolio management for pooled investment vehicles (other than investment companies)"],"financialPlanningClients":null,"assetMix":[],"privateFunds":3},"sources":{"adv1FilingDate":"30 March 2026","adv1Url":"https://reports.adviserinfo.sec.gov/reports/ADV/153232/PDF/153232.pdf","brochureDate":null,"brochureUrl":null,"iapdCompiledDate":null,"retrievedDate":"15 October 2026","retrievedOn":"2026-10-15","adv1Pages":{},"brochurePages":{}},"otherBusiness":[],"faq":[{"question":"How many clients does RTW Investments have?","answer":"RTW Investments has 10 clients and manages $14.1 billion for them, as of March 2026.","source":"Form ADV Part 1A, Items 5.D and 5.F, filed 30 March 2026","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What services does RTW Investments offer?","answer":"RTW Investments provides portfolio management for pooled vehicles.","source":"Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"How many financial advisors does RTW Investments have?","answer":"RTW Investments has 0 investment adviser representatives registered with state securities authorities, out of 70 employees, and 35 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.","source":"Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Who owns RTW Investments?","answer":"RTW Investments’ direct owners are Roderick Wong (50% to 75%) and Naveen Yalamanchi (5% to 10%).","source":"Form ADV Part 1A, Schedules A and B, filed 30 March 2026","sourceRef":{"doc":"adv1","section":"scheduleA"}},{"question":"How does RTW Investments get paid?","answer":"RTW Investments is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.","source":"Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}}],"holdings":{"url":"https://nivawealth.com/firms/rtw-investments-153232/holdings","form":"13F-HR","periodOfReport":"2026-06-30","filedOn":"2026-08-14","filingIndexUrl":"https://www.sec.gov/Archives/edgar/data/1493215/000149321526000164/0001493215-26-000164-index.html","totalValue":11712926784,"positionCount":84,"top10Share":0.4771536195918562,"top10":[{"issuer":"MADRIGAL PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"558868105","value":1070510235,"shares":1993687,"shareType":"SH","priorValue":1043635334,"priorShares":1993687},{"issuer":"ARGENX SE","titleOfClass":"SPONSORED ADR","cusip":"04016X101","value":658202715,"shares":709446,"shareType":"SH","priorValue":518072942,"priorShares":709446},{"issuer":"PTC THERAPEUTICS INC","titleOfClass":"COM","cusip":"69366J200","value":631875072,"shares":7746415,"shareType":"SH","priorValue":527763254,"priorShares":7746415},{"issuer":"PROTAGONIST THERAPEUTICS INC","titleOfClass":"COM","cusip":"74366E102","value":620398832,"shares":5061175,"shareType":"SH","priorValue":533224186,"priorShares":5059053},{"issuer":"CG ONCOLOGY INC","titleOfClass":"COM","cusip":"156944100","value":604961620,"shares":8514590,"shareType":"SH","priorValue":472731805,"priorShares":6984808},{"issuer":"INSMED INC","titleOfClass":"COM PAR $.01","cusip":"457669307","value":516347866,"shares":4842880,"shareType":"SH","priorValue":791907738,"priorShares":4842880},{"issuer":"TANGO THERAPEUTICS INC","titleOfClass":"COM","cusip":"87583X109","value":434533381,"shares":13900620,"shareType":"SH","priorValue":278248970,"priorShares":13300620},{"issuer":"SPYRE THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"00773J202","value":377492205,"shares":4251996,"shareType":"SH","priorValue":210435478,"priorShares":4171996},{"issuer":"CELCUITY INC","titleOfClass":"COM","cusip":"15102K100","value":345758952,"shares":3304903,"shareType":"SH","priorValue":346942341,"priorShares":3039621},{"issuer":"ERASCA INC","titleOfClass":"COM","cusip":"29479A108","value":328784533,"shares":17946754,"shareType":"SH","priorValue":261423092,"priorShares":16157175}],"positionsListed":84,"positions":[{"issuer":"MADRIGAL PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"558868105","value":1070510235,"shares":1993687,"shareType":"SH","priorValue":1043635334,"priorShares":1993687},{"issuer":"ARGENX SE","titleOfClass":"SPONSORED ADR","cusip":"04016X101","value":658202715,"shares":709446,"shareType":"SH","priorValue":518072942,"priorShares":709446},{"issuer":"PTC THERAPEUTICS INC","titleOfClass":"COM","cusip":"69366J200","value":631875072,"shares":7746415,"shareType":"SH","priorValue":527763254,"priorShares":7746415},{"issuer":"PROTAGONIST THERAPEUTICS INC","titleOfClass":"COM","cusip":"74366E102","value":620398832,"shares":5061175,"shareType":"SH","priorValue":533224186,"priorShares":5059053},{"issuer":"CG ONCOLOGY INC","titleOfClass":"COM","cusip":"156944100","value":604961620,"shares":8514590,"shareType":"SH","priorValue":472731805,"priorShares":6984808},{"issuer":"INSMED INC","titleOfClass":"COM PAR $.01","cusip":"457669307","value":516347866,"shares":4842880,"shareType":"SH","priorValue":791907738,"priorShares":4842880},{"issuer":"TANGO THERAPEUTICS INC","titleOfClass":"COM","cusip":"87583X109","value":434533381,"shares":13900620,"shareType":"SH","priorValue":278248970,"priorShares":13300620},{"issuer":"SPYRE THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"00773J202","value":377492205,"shares":4251996,"shareType":"SH","priorValue":210435478,"priorShares":4171996},{"issuer":"CELCUITY INC","titleOfClass":"COM","cusip":"15102K100","value":345758952,"shares":3304903,"shareType":"SH","priorValue":346942341,"priorShares":3039621},{"issuer":"ERASCA INC","titleOfClass":"COM","cusip":"29479A108","value":328784533,"shares":17946754,"shareType":"SH","priorValue":261423092,"priorShares":16157175},{"issuer":"RADNET INC","titleOfClass":"COM","cusip":"750491102","value":298911900,"shares":4846958,"shareType":"SH","priorValue":239488650,"priorShares":4285000},{"issuer":"ORUKA THERAPEUTICS INC","titleOfClass":"COM","cusip":"687604108","value":298741485,"shares":3139030,"shareType":"SH","priorValue":100952159,"priorShares":2058148},{"issuer":"NATERA INC","titleOfClass":"COM","cusip":"632307104","value":271450000,"shares":1000000,"shareType":"SH","priorValue":249987500,"priorShares":1250000},{"issuer":"ULTRAGENYX PHARMACEUTICAL IN","titleOfClass":"COM","cusip":"90400D108","value":260338324,"shares":7796895,"shareType":"SH","priorValue":76442255,"priorShares":3648795},{"issuer":"IRHYTHM HOLDINGS INC","titleOfClass":"COM","cusip":"450056106","value":259623957,"shares":2182631,"shareType":"SH","priorValue":196916370,"priorShares":1668500},{"issuer":"CYTOKINETICS INC","titleOfClass":"COM NEW","cusip":"23282W605","value":243814036,"shares":2862003,"shareType":"SH","priorValue":179351524,"priorShares":2721158},{"issuer":"KAILERA THERAPEUTICS INC","titleOfClass":"COMMON STOCK","cusip":"482931102","value":237413345,"shares":10776820,"shareType":"SH"},{"issuer":"ESTABLISHMENT LABS HLDGS INC","titleOfClass":"COM","cusip":"G31249108","value":227885188,"shares":2655695,"shareType":"SH","priorValue":150790362,"priorShares":2655695},{"issuer":"GUARDANT HEALTH INC","titleOfClass":"COM","cusip":"40131M109","value":222199381,"shares":1481033,"shareType":"SH","priorValue":136803018,"priorShares":1481033},{"issuer":"NEUROCRINE BIOSCIENCES INC","titleOfClass":"COM","cusip":"64125C109","value":213689740,"shares":1267925,"shareType":"SH","priorValue":139917365,"priorShares":1062072},{"issuer":"TARSUS PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"87650L103","value":211293293,"shares":3357059,"shareType":"SH","priorValue":234723654,"priorShares":3346025},{"issuer":"STOKE THERAPEUTICS INC","titleOfClass":"COM","cusip":"86150R107","value":184001738,"shares":5623525,"shareType":"SH","priorValue":183101974,"priorShares":5623525},{"issuer":"UNIQURE NV","titleOfClass":"SHS","cusip":"N90064101","value":181548806,"shares":3941572,"shareType":"SH","priorValue":42286921,"priorShares":2586356},{"issuer":"ACADIA PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"004225108","value":180756457,"shares":7144524,"shareType":"SH","priorValue":159037104,"priorShares":7144524},{"issuer":"REPLIGEN CORP","titleOfClass":"COM","cusip":"759916109","value":169272512,"shares":1240637,"shareType":"SH","priorValue":142090920,"priorShares":1206000},{"issuer":"UROGEN PHARMA LTD","titleOfClass":"COM","cusip":"M96088105","value":167215336,"shares":4543895,"shareType":"SH","priorValue":81699232,"priorShares":4543895},{"issuer":"GH RESEARCH PLC","titleOfClass":"ORDINARY SHARES","cusip":"G3855L106","value":159500947,"shares":5933815,"shareType":"SH","priorValue":83429439,"priorShares":5933815},{"issuer":"IMMUNOCORE HLDGS PLC","titleOfClass":"ADS","cusip":"45258D105","value":154616087,"shares":4869798,"shareType":"SH","priorValue":146824410,"priorShares":4869798},{"issuer":"COMPASS PATHWAYS PLC","titleOfClass":"SPONSORED ADS","cusip":"20451W101","value":151418782,"shares":10700974,"shareType":"SH","priorValue":58797117,"priorShares":10632390},{"issuer":"IMMATICS N.V","titleOfClass":"SHS","cusip":"N44445109","value":131144763,"shares":12946176,"shareType":"SH","priorValue":126634306,"priorShares":12869340},{"issuer":"ZAI LAB LTD","titleOfClass":"ADR","cusip":"98887Q104","value":124906608,"shares":6574032,"shareType":"SH","priorValue":123657542,"priorShares":6574032},{"issuer":"IMMUNOVANT INC","titleOfClass":"COM","cusip":"45258J102","value":122442522,"shares":3177849,"shareType":"SH","priorValue":78937769,"priorShares":3177849},{"issuer":"BELITE BIO INC","titleOfClass":"SPONSORED ADS","cusip":"07782B104","value":110150398,"shares":715332,"shareType":"SH","priorValue":114052534,"priorShares":715332},{"issuer":"XENCOR INC","titleOfClass":"COM","cusip":"98401F105","value":109117122,"shares":6777461,"shareType":"SH","priorValue":81736180,"priorShares":6777461},{"issuer":"TAYSHA GENE THERAPIES INC","titleOfClass":"COM SHS","cusip":"877619106","value":92345357,"shares":13560258,"shareType":"SH","priorValue":61150709,"priorShares":13680248},{"issuer":"COGENT BIOSCIENCES INC","titleOfClass":"COM","cusip":"19240Q201","value":89359113,"shares":2309021,"shareType":"SH","priorValue":210104401,"priorShares":5458675},{"issuer":"ALKERMES PLC","titleOfClass":"SHS","cusip":"G01767105","value":87623093,"shares":1672356,"shareType":"SH","priorValue":59134508,"priorShares":1672356},{"issuer":"STRUCTURE THERAPEUTICS INC","titleOfClass":"SPONSORED ADS","cusip":"86366E106","value":86274901,"shares":1607507,"shareType":"SH"},{"issuer":"REPLIMUNE GROUP INC","titleOfClass":"COM","cusip":"76029N106","value":82046202,"shares":7411581,"shareType":"SH","priorValue":56280407,"priorShares":7356916},{"issuer":"CASTLE BIOSCIENCES INC","titleOfClass":"COM","cusip":"14843C105","value":66263290,"shares":2778335,"shareType":"SH","priorValue":67717124,"priorShares":2758335},{"issuer":"CANDEL THERAPEUTICS INC","titleOfClass":"COM","cusip":"137404109","value":66146785,"shares":6422018,"shareType":"SH","priorValue":31467888,"priorShares":6422018},{"issuer":"ROCKET PHARMACEUTICALS INC","titleOfClass":"COM","cusip":"77313F106","value":60492180,"shares":17687772,"shareType":"SH","priorValue":63322224,"priorShares":17687772},{"issuer":"KODIAK SCIENCES INC","titleOfClass":"COM","cusip":"50015M109","value":57969909,"shares":1487934,"shareType":"SH","priorValue":56720044,"priorShares":1487934},{"issuer":"AKTIS ONCOLOGY INC","titleOfClass":"COM","cusip":"01021M104","value":51311546,"shares":1592043,"shareType":"SH","priorValue":28481649,"priorShares":1592043},{"issuer":"AXOGEN INC","titleOfClass":"COM","cusip":"05463X106","value":46724695,"shares":1011576,"shareType":"SH"},{"issuer":"DANAHER CORP DEL","titleOfClass":"COM","cusip":"235851102","value":43810400,"shares":230000,"shareType":"SH"},{"issuer":"CULLINAN THERAPEUTICS INC","titleOfClass":"COM","cusip":"230031106","value":43054759,"shares":2364347,"shareType":"SH","priorValue":24241692,"priorShares":1705960},{"issuer":"NEUROGENE INC","titleOfClass":"COM","cusip":"64135M105","value":42849241,"shares":1362456,"shareType":"SH","priorValue":27467113,"priorShares":1362456},{"issuer":"HINGE HEALTH INC","titleOfClass":"CL A","cusip":"433313103","value":41500000,"shares":500000,"shareType":"SH","priorValue":74420800,"priorShares":1930000},{"issuer":"ORCHESTRA BIOMED HLDGS INC","titleOfClass":"COM","cusip":"68572M106","value":41234412,"shares":9556063,"shareType":"SH","priorValue":35300768,"priorShares":8306063},{"issuer":"SOLID BIOSCIENCES INC","titleOfClass":"COM NEW","cusip":"83422E204","value":38890331,"shares":3892926,"shareType":"SH"},{"issuer":"SAVARA INC","titleOfClass":"COM","cusip":"805111101","value":36666661,"shares":5952380,"shareType":"SH","priorValue":32499995,"priorShares":5952380},{"issuer":"AQUESTIVE THERAPEUTICS INC","titleOfClass":"COM","cusip":"03843E104","value":30894119,"shares":7426471,"shareType":"SH","priorValue":30819855,"priorShares":7426471},{"issuer":"KYMERA THERAPEUTICS INC","titleOfClass":"COM","cusip":"501575104","value":27520800,"shares":240000,"shareType":"SH","priorValue":19989600,"priorShares":240000},{"issuer":"VERASTEM INC","titleOfClass":"COM NEW","cusip":"92337C203","value":25348729,"shares":6635793,"shareType":"SH","priorValue":34854422,"priorShares":6576306},{"issuer":"DIANTHUS THERAPEUTICS INC","titleOfClass":"COM","cusip":"252828108","value":24181181,"shares":248063,"shareType":"SH","priorValue":20817447,"priorShares":248063},{"issuer":"BETA BIONICS INC","titleOfClass":"COM","cusip":"08659B102","value":23505000,"shares":1500000,"shareType":"SH","priorValue":20040000,"priorShares":2000000},{"issuer":"CENTURY THERAPEUTICS INC","titleOfClass":"COM","cusip":"15673T100","value":21304347,"shares":8695652,"shareType":"SH","priorValue":19652174,"priorShares":8695652},{"issuer":"EVOMMUNE INC","titleOfClass":"COM SHS","cusip":"30054Y107","value":19964703,"shares":1502235,"shareType":"SH","priorValue":34536383,"priorShares":1502235},{"issuer":"BEAM THERAPEUTICS INC","titleOfClass":"COM","cusip":"07373V105","value":19575922,"shares":570394,"shareType":"SH","priorValue":13592489,"priorShares":570394},{"issuer":"DEFINIUM THERAPEUTICS INC","titleOfClass":"COM SHS","cusip":"24477V105","value":18816000,"shares":400000,"shareType":"SH","priorValue":5670000,"priorShares":300000},{"issuer":"IDEAYA BIOSCIENCES INC","titleOfClass":"COM","cusip":"45166A102","value":13803690,"shares":370370,"shareType":"SH"},{"issuer":"ATAIBECKLEY INC","titleOfClass":"COM SHS","cusip":"04650F101","value":10540000,"shares":2000000,"shareType":"SH","priorValue":7080000,"priorShares":2000000},{"issuer":"MILESTONE PHARMACEUTICALS IN","titleOfClass":"COM","cusip":"59935V107","value":10496670,"shares":7833336,"shareType":"SH","priorValue":7533891,"priorShares":6331001},{"issuer":"OCUGEN INC","titleOfClass":"COM","cusip":"67577C105","value":10199999,"shares":6666666,"shareType":"SH","priorValue":12066665,"priorShares":6666666},{"issuer":"TENAX THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"88032L605","value":10135094,"shares":696570,"shareType":"SH","priorValue":5920234,"priorShares":370246},{"issuer":"HEARTFLOW INC","titleOfClass":"COM","cusip":"42238D107","value":8655300,"shares":295000,"shareType":"SH","priorValue":12043350,"priorShares":495000},{"issuer":"PERCEPTIVE CAP SOLUTIONS COR","titleOfClass":"CL A ORD SHS","cusip":"G70077105","value":8078400,"shares":742500,"shareType":"SH","priorValue":8145225,"priorShares":742500},{"issuer":"WAVE LIFE SCIENCES LTD","titleOfClass":"SHS","cusip":"Y95308105","value":7843500,"shares":1350000,"shareType":"SH","priorValue":9787500,"priorShares":1350000},{"issuer":"LARIMAR THERAPEUTICS INC","titleOfClass":"COM","cusip":"517125100","value":7826297,"shares":2565999,"shareType":"SH","priorValue":6750000,"priorShares":1500000},{"issuer":"LUMEXA IMAGING HOLDINGS INC","titleOfClass":"COM","cusip":"550249106","value":7332000,"shares":650000,"shareType":"SH","priorValue":5590000,"priorShares":650000},{"issuer":"ALLOGENE THERAPEUTICS INC","titleOfClass":"COM","cusip":"019770106","value":6760000,"shares":3250000,"shareType":"SH"},{"issuer":"CRESCENT BIOPHARMA INC.","titleOfClass":"COM","cusip":"G2545C104","value":6711408,"shares":372856,"shareType":"SH","priorValue":6849365,"priorShares":372856},{"issuer":"4D MOLECULAR THERAPEUTICS IN","titleOfClass":"COM","cusip":"35104E100","value":6327302,"shares":475737,"shareType":"SH","priorValue":4429111,"priorShares":475737},{"issuer":"MAZE THERAPEUTICS INC","titleOfClass":"COM","cusip":"578784100","value":6326080,"shares":212000,"shareType":"SH"},{"issuer":"CAPRICOR THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"14070B309","value":6020000,"shares":250000,"shareType":"SH","priorValue":7600000,"priorShares":250000},{"issuer":"KALARIS THERAPEUTICS INC","titleOfClass":"COM","cusip":"482929106","value":5291000,"shares":1300000,"shareType":"SH","priorValue":7501000,"priorShares":1300000},{"issuer":"ABIVAX SA","titleOfClass":"SPONSORED ADS","cusip":"00370M103","value":3518064,"shares":26400,"shareType":"SH"},{"issuer":"AVALO THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"05338F306","value":3234000,"shares":175000,"shareType":"SH","priorValue":12794443,"priorShares":856962},{"issuer":"MEDLINE INC","titleOfClass":"COM CL A","cusip":"58507V107","value":2760800,"shares":70000,"shareType":"SH","priorValue":3115000,"priorShares":70000},{"issuer":"DISC MEDICINE INC","titleOfClass":"COM","cusip":"254604101","value":2194200,"shares":30000,"shareType":"SH","priorValue":1918200,"priorShares":30000},{"issuer":"IMAGENEBIO INC","titleOfClass":"COM","cusip":"45175G207","value":1973226,"shares":334445,"shareType":"SH","priorValue":1672225,"priorShares":334445},{"issuer":"EXAGEN INC","titleOfClass":"COM","cusip":"30068X103","value":906750,"shares":195000,"shareType":"SH","priorValue":1185693,"priorShares":395231},{"issuer":"ROCKET PHARMACEUTICALS INC","titleOfClass":"*W EXP 09/02/202","cusip":"77313F114","value":1190,"shares":350000,"shareType":"SH","priorValue":7210,"priorShares":350000}]},"notice":"Compiled from public SEC Form ADV filings on the dates in `sources`. Facts as filed; not a rating, ranking, or recommendation. Niva Wealth is not affiliated with this firm. Disciplinary history is deliberately not included here or on the page; the SEC publishes the complete record at the `iapdUrl` above."}